MMP9 and Stroke: Although not discounting the contribution of neutrophil-derived MMP-9 in barrier disruption and evolution of injury following stroke, this group suggest that neutrophils are not the primary source of MMP-9 following stroke and that other cell types such as microglia, astrocytes, and endothelial cells may be more appropriate targets for MMP inhibition.